Clinical Trials Logo

Asthma, Aspirin-Induced clinical trials

View clinical trials related to Asthma, Aspirin-Induced.

Filter by:

NCT ID: NCT01320072 Terminated - Clinical trials for Asthma, Aspirin-induced

Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease

ASAS
Start date: May 2010
Phase:
Study type: Observational

To diagnose aspirin hypersensitivity in asthmatics by using and safe, low-dose aspirin oral challenge. Hypothesis 1: A low dose of oral ASA (20 or 40 mg) will induce significantly different concentrations of arachidonic acid metabolites in ASA-sensitive asthmatics as compared to ASA-tolerant asthmatics. Hypothesis 2: The low dose (20 or 40 mg) ASA challenge will be well tolerated by ASA-sensitive asthmatics.